U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C34H29ClN6O3
Molecular Weight 605.085
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MODIPAFANT

SMILES

CCOC(=O)C1=C(NC(C)=C([C@H]1C2=CC=CC=C2Cl)C(=O)NC3=NC=CC=C3)C4=CC=C(C=C4)N5C(C)=NC6=C5C=CN=C6

InChI

InChIKey=ODRYSCQFUGFOSU-SSEXGKCCSA-N
InChI=1S/C34H29ClN6O3/c1-4-44-34(43)31-30(24-9-5-6-10-25(24)35)29(33(42)40-28-11-7-8-17-37-28)20(2)38-32(31)22-12-14-23(15-13-22)41-21(3)39-26-19-36-18-16-27(26)41/h5-19,30,38H,4H2,1-3H3,(H,37,40,42)/t30-/m1/s1

HIDE SMILES / InChI

Molecular Formula C34H29ClN6O3
Molecular Weight 605.085
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Modipafant is a dihydropyridine derivative patented by American multinational pharmaceutical corporation Pfizer Ltd. as platelet-activating factor antagonist for bronchoconstriction and asthma treatment. Platelet-activating factor, proposed as an important inflammatory mediator in asthma, reproduces several of the features of asthma, such as microvascular leakage, mucus secretion, bronchoconstriction, and possibly increased airway responsiveness. Unfortunately, in clinical trials, Modipafant failed to demonstrate superior efficacy compared to placebo.

Approval Year

PubMed

PubMed

TitleDatePubMed
Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma.
1995 May
Patents

Patents

Sample Use Guides

50 mg capsule twice daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:02:54 GMT 2023
Edited
by admin
on Fri Dec 15 16:02:54 GMT 2023
Record UNII
1DMI0E5023
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MODIPAFANT
INN  
INN  
Official Name English
ETHYL (+)-(R)-4-(O-CHLOROPHENYL)-1,4-DIHYDRO-6-METHYL-2-(P-(2-METHYL-1H-IMIDAZO(4,5-C)PYRIDIN-1-YL)PHENYL)-5-(2-PYRIDYLCARBAMOYL)NICOTINATE
Common Name English
UK-80067
Code English
modipafant [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
Code System Code Type Description
MESH
C073027
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
FDA UNII
1DMI0E5023
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
EPA CompTox
DTXSID30153811
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
EVMPD
SUB09029MIG
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
INN
6828
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
SMS_ID
100000080350
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105829
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
CAS
122957-06-6
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
NCI_THESAURUS
C90752
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
PUBCHEM
3047770
Created by admin on Fri Dec 15 16:02:54 GMT 2023 , Edited by admin on Fri Dec 15 16:02:54 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
RACEMATE -> ENANTIOMER
Related Record Type Details
ACTIVE MOIETY